COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

26,717 Articles (20,130 medRxiv, 6,587 bioRxiv)

Most recent first Page 1: Articles 1-10  | Next

Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatment
Creisher, P. S., Perry, J. L., Zhong, W., Lei, J., Mulka, K. R., Ryan, H., Zhou, R., Akin, E. H., Liu, A., Mitzner, W., Burd, I., Pekosz, A., Klein, S. L.
10.1101/2023.03.23.533961 — Posted: 2023-03-23
Estimating the Impact of Pre-Exposure Prophylaxis (PrEP) on Mortality in COVID-19 Patients: A Causal Inference Approach
Subramanian, A., Huang, Y., Pinto, M. D., Downs, C. A., Rahmani, A.
10.1101/2023.03.16.23287365 — Posted: 2023-03-23
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
Perera, D. J., Domenech, P., Babuadze, G. G., Naghibosadat, M., Alvarez, F., Koger-Pease, C., Labrie, L., Stuible, M., Durocher, Y., Piccirillo, C. A., Lametti, A., Fiset, P. O., Elahi, S. M., Kobinger, G. P., Gilbert, R., Olivier, M., Kozak, R., Reed, M. B., Ndao, M.
10.1101/2023.03.21.533720 — Posted: 2023-03-22
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Wang, Q., Li, Z., Guo, Y., Mellis, I. A., Iketani, S., Liu, M., Yu, J., Valdez, R., Lauring, A. S., Sheng, Z., Gordon, A., Liu, L., Ho, D. D.
10.1101/2023.03.22.533805 — Posted: 2023-03-22
COVID-19 Genome Surveillance: A Geographical Landscape and Mutational Mapping of SARS-CoV-2 Variants in Central India over Two Years
Khairnar, K., Tomar, S. S.
10.1101/2023.03.22.23287566 — Posted: 2023-03-22
How influenza vaccination changed over the COVID-19 pandemic?
Yang, Y.
10.1101/2023.03.21.23287546 — Posted: 2023-03-22
Coverage of state-initiated contact-tracing during COVID-19 and factors influencing it: evidence from real-world data
Mongin, D., Burgisser, N., Courvoisier, D. S., Covid-SMC Study Group
10.1101/2023.03.22.23287577 — Posted: 2023-03-22
Inter-rater reliability of the Infectious Disease Modeling Reproducibility Checklist (IDMRC) as applied to COVID-19 computational modeling research
Pokutnaya, D., Van Panhuis, W. G., Childers, B., Hawkins, M. S., Arcury-Quandt, A. E., Matlack, M., Carpio, K., Hochheiser, H.
10.1101/2023.03.21.23287529 — Posted: 2023-03-22
Gut microbiome predicts atopic diseases in an infant cohort with reduced bacterial exposure due to social distancing
Korpela, K., Hurley, S., Ahearn-Ford, S., Franklin, R., Byrne, S., Lunjani, N., Forde, B., Neogi, U., Venter, C., Walter, J., Hourihane, J., O'Mahony, L.
10.1101/2023.03.22.23287583 — Posted: 2023-03-22
Comparison of Vaccination and Booster Rates and Their Impact on Excess Mortality During the COVID-19 Pandemic in European Countries
Matveeva, O., Shabalina, S. A.
10.1101/2023.03.21.23287548 — Posted: 2023-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).